Metoprolol Tartrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 30 USDMF, 17 CEP/COS, 3 JDMF, 7 EU WC, 14 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

7 Intermediates Suppliers

7 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

350 FDF Dossiers, 81 FDA Orange Book, 134 Europe, 38 Canada, 28 Australia, 1 South Africa, 68 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 50MG, INJECTABLE;INJECTION - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 3 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 1 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 15 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 35 Direct Compression, 29 Disintegrants & Superdisintegrants, 29 Solubilizers, 29 Controlled & Modified Release, 27 Thickeners and Stabilizers, 25 Granulation, 21 Lubricants & Glidants, 19 Co-Processed Excipients, 19 Topical, 18 Parenteral, 17 Film Formers & Plasticizers, 10 Taste Masking, 9 Emulsifying Agents, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Coloring Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 122 Finished Drug Prices, 14 Annual Reports

MARKET PLACE

16 APIs, 11 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 20 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 18704 / DOSAGE - INJECTABLE;INJECTION - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
METOPROLOL TARTRATE(UNII: W5S57Y3A5L) (METOPROLOL - UNII:GEB06NHM23)	METOPROLOL TARTRATE	5mg in 5

Inactive Ingredients

Ingredient Name	Novartis Pharmaceuticals Corporation
SODIUM CHLORIDE(451W47IQ8X)
WATER(059QF0KO0R)

Drug Product Composition: Metoprolol Tartrate